Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

NextCure, Inc. - Common Stock (NQ:NXTC)

11.25 +0.11 (+0.99%)
Streaming Delayed Price Updated: 9:30 AM EST, Dec 15, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about NextCure, Inc. - Common Stock

< Previous 1 2 3 4 5 Next >
News headline image
12 Health Care Stocks Moving In Thursday's Intraday Session ↗
 
Via Benzinga
News headline image
US Stocks Higher; Initial Jobless Claims Fall To 202,000 ↗
U.S. stocks traded higher this morning, following the release of economic reports on Thursday. Following the market opening Thursday, the Dow traded up 0.24% to 37,180.82 while the NASDAQ rose 0.60% to... 
Via Benzinga
Topics Stocks
News headline image
12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗
 
Via Benzinga
News headline image
NextCure Provides Year-End Clinical Pipeline Updates
From NextCure
Via GlobeNewswire
News headline image
NextCure, LegoChem Biosciences Ink Collaborative Pact For Antibody Drug Conjugates ↗
 
Via Benzinga
News headline image
NextCure to Present at the 35th Annual Piper Sandler Healthcare Conference
From NextCure
Via GlobeNewswire
News headline image
NextCure Publishes Non-Clinical Data Defining the Mechanism of Action for NC525, a Novel LAIR-1 Antibody for AML
From NextCure
Via GlobeNewswire
News headline image
NextCure Provides Business Update and Reports Third Quarter 2023 Financial Results
From NextCure
Via GlobeNewswire
News headline image
Preclinical Data Demonstrate Anti-Siglec-15 Treatment Reduced Bone Loss and Enhanced Bone Quality in Mice with Moderate-to-Severe Osteogenesis Imperfecta (OI)
Data Presented at the 2023 American Society for Bone and Mineral Research (ASBMR) Annual Meeting 
From NextCure
Via GlobeNewswire
News headline image
NextCure Presents Preclinical Data on NC181, a Novel Therapeutic Candidate Targeting ApoE4, for the Treatment of Alzheimer’s Disease
From NextCure
Via GlobeNewswire
News headline image
A Phase 2 Study of Anti-Siglec-15 Antibody, NC318, in Combination with Pembrolizumab (NCT04699123) Demonstrates Clinical Activity in Patients with Advanced PD-1 Axis Inhibitor Refractory NSCLC
From NextCure
Via GlobeNewswire
News headline image
NextCure and Nordic Bioscience Publish Review Article on the Regulation of Tumor Immunity by Tumor Collagen
From NextCure
Via GlobeNewswire
News headline image
Preclinical Data Demonstrate Potential Application of Anti-Siglec-15 Treatment in Bone Disease
From NextCure
Via GlobeNewswire
News headline image
NextCure to Present at the H.C. Wainwright 25th Annual Global Investment Conference
From NextCure
Via GlobeNewswire
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For August 8, 2023 ↗
 
Via Benzinga
News headline image
NextCure Provides Business Update and Reports Second Quarter 2023 Financial Results
From NextCure
Via GlobeNewswire
News headline image
NextCure Presents Non-Clinical Data Defining the Mechanism of NC525 at the 2023 Federation of Clinical Immunology Societies (FOCIS) Annual Meeting
From NextCure
Via GlobeNewswire
News headline image
12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗
 
Via Benzinga
News headline image
NextCure to Present at the JMP Securities Life Sciences Conference
From NextCure
Via GlobeNewswire
News headline image
NextCure Provides Business Update and Reports First Quarter 2023 Financial Results
From NextCure
Via GlobeNewswire
News headline image
NextCure to Present at 22nd Annual Needham Virtual Healthcare Conference
From NextCure
Via GlobeNewswire
News headline image
NextCure Provides Business Update and Reports Full Year 2022 Financial Results
From NextCure
Via GlobeNewswire
News headline image
NextCure to Present at SVB Securities Global Biopharma Conference
From NextCure
Via GlobeNewswire
News headline image
Stocks That Hit 52-Week Lows On Tuesday ↗
  On Tuesday, 89 companies set new 52-week lows. 
Via Benzinga
News headline image
NextCure to Present at Upcoming Investor Conferences
From NextCure
Via GlobeNewswire
News headline image
Stocks That Hit 52-Week Lows On Monday ↗
  On Monday, 79 companies reached new 52-week lows. 
Via Benzinga
News headline image
NextCure and LegoChem Biosciences Enter into Collaboration and Co-Development Agreement to Develop Antibody Drug Conjugates
From NextCure
Via GlobeNewswire
News headline image
Stocks That Hit 52-Week Lows On Thursday ↗
  During Thursday's session, 97 companies made new 52-week lows. 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Monday's Intraday Session ↗
Gainers 
Via Benzinga
News headline image
NextCure Presents Initial Data from Clinical Trial of NC762 and a Trial in Progress Poster for NC410 Combo at the 2022 Society for Immunotherapy of Cancer Annual Meeting
From NextCure
Via GlobeNewswire
< Previous 1 2 3 4 5 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.